PMID: 9542990May 30, 1998Paper

Piperacillin/tazobactam therapy for diabetic foot infection

Foot & Ankle International
A M ZeillemakerR J Diepersloot

Abstract

In this study, 29 patients were hospitalized with a diabetic foot infection and were treated with piperacillin/tazobactam. Of these 23 patients who were evaluated for efficacy of treatment, 22 patients improved or were clinically cured. In seven patients (30%), there was persistence of one of the baseline pathogens. Adverse events were reported in 15 patients (58%), three of which were serious. Piperacillin/tazobactam may be useful as monotherapy in diabetic foot infection giving an adequate clinical response and the level of side effects equivalent to those of other broad-spectrum antibiotics.

References

Nov 1, 1988·The Medical Clinics of North America·A J Boulton
Oct 1, 1986·Archives of Internal Medicine·L J WheatJ Norton
Sep 1, 1980·Journal of Clinical Microbiology·F L SapicoA N Bessman
Sep 29, 1994·The New England Journal of Medicine·G M CaputoA W Karchmer

❮ Previous
Next ❯

Citations

Oct 21, 2005·Advances in Therapy·Thomas Zgonis, Thomas S Roukis
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F G PeraltaR Arjona
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin A Lipsky
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin A LipskyUNKNOWN Infectious Diseases Society of America
Jun 27, 2006·Plastic and Reconstructive Surgery·Benjamin A LipskyUNKNOWN Infectious Diseases Society of America
Jul 5, 2007·Journal of Clinical Microbiology·Diane M CitronMurray A Abramson
Mar 11, 2005·Expert Opinion on Pharmacotherapy·Eric Senneville
Oct 16, 2007·The Surgical Clinics of North America·Charles A Andersen, Thomas S Roukis
Apr 14, 2007·Clinics in Podiatric Medicine and Surgery·John S SteinbergMark R Abbruzzese
Oct 31, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·S EspositoE Sarli
Nov 26, 2003·Clinics in Podiatric Medicine and Surgery·Thomas ZgonisPeter Blume
Jul 14, 2000·Journal of the American Geriatrics Society·M E Temple, M C Nahata
Nov 27, 1999·FEMS Immunology and Medical Microbiology·B A Lipsky
Oct 17, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N SaltogluM Sert
Jun 20, 2017·Expert Opinion on Pharmacotherapy·Kohei TakimotoYoshiro Hayashi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.